Logo der Universität Basel

Research Database / FORSCHUNGSDATENBANK 
PRINTDOC
 
Publication 1194531 | Verified
 

Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1194531
Author(s) Szucs, T. D.; Blank, P. R.; Schwenkglenks, M.; Aapro, M.
Author(s) at UniBasel Blank, Patricia R.
Schwenkglenks, Matthias
Year 2011
Title Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia
Journal Oncology
Volume 81
Number 1
Pages / Article-Number 45-9
Keywords Chemotherapy-induced anemia, Iron deficiency, Iron supplementation
Abstract Intravenous (i.v.) iron supplementation significantly improves the response to erythropoiesis-stimulating agent (ESA)-based therapies in patients with cancer- or chemotherapy-induced anemia. The economic implications of adding i.v. iron to ESA treatment are less well investigated. Published randomized controlled trials do not provide sufficient data for a comprehensive cost-effectiveness analysis.
Publisher Karger
ISSN/ISBN 0030-2414 ; 1423-0232
edoc-URL http://edoc.unibas.ch/dok/A6004745
Full Text on edoc Available
Digital Object Identifier DOI 10.1159/000330738
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/21921645
ISI-Number WOS:000294954600008
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.340 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/05/2024